| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Potentially dilutive securities outlined in the table below have
been excluded from the computation of diluted net loss per share
because the effect of their inclusion would have been
anti-dilutive.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
For the Years Ended
December 31, |
|
| |
|
2017 |
|
|
2016 |
|
|
2015 |
|
|
Consulting Warrant to purchase common stock
|
|
|
— |
|
|
|
— |
|
|
|
146,252 |
|
|
Financing Warrant to purchase common stock
|
|
|
13,889 |
|
|
|
13,889 |
|
|
|
152,778 |
|
|
IPO Warrants to purchase common stock
|
|
|
11,600 |
|
|
|
11,600 |
|
|
|
460,000 |
|
|
IR Consulting Warrant
|
|
|
— |
|
|
|
23,250 |
|
|
|
36,000 |
|
|
IR Incentive Warrant
|
|
|
— |
|
|
|
15,000 |
|
|
|
15,000 |
|
|
Warrants issued to private investors
|
|
|
3,035,688 |
|
|
|
2,381,675 |
|
|
|
— |
|
|
Options to purchase common stock
|
|
|
1,037,239 |
|
|
|
1,309,444 |
|
|
|
1,487,785 |
|
|
RSUs
|
|
|
2,274,327 |
|
|
|
2,052,223 |
|
|
|
1,560,996 |
|
|
PSUs
|
|
|
951,657 |
|
|
|
1,153,617 |
|
|
|
1,135,614 |
|
|
DSUs
|
|
|
— |
|
|
|
14,953 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total potentially dilutive securities
|
|
|
7,324,400 |
|
|
|
6,975,651 |
|
|
|
4,994,425 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|